Trial Profile
An open-label pilot clinical trial of MAGE-A3 and MAGE-C1 mRNA electroporated autologous dendritic cell vaccination in combination with lenalidomide maintenance therapy for multiple myeloma after first-line autologous stem cell transplantation.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2017
Price :
$35
*